BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garcia-Broncano P, Maddali S, Einkauf KB, Jiang C, Gao C, Chevalier J, Chowdhury FZ, Maswabi K, Ajibola G, Moyo S, Mohammed T, Ncube T, Makhema J, Jean-Philippe P, Yu XG, Powis KM, Lockman S, Kuritzkes DR, Shapiro R, Lichterfeld M. Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile. Sci Transl Med 2019;11:eaax7350. [PMID: 31776292 DOI: 10.1126/scitranslmed.aax7350] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 16.7] [Reference Citation Analysis]
Number Citing Articles
1 Aldrovandi GM, Tobin NH. Immunopathogenesis of HIV-1 Infection. Principles and Practice of Pediatric Infectious Diseases 2023. [DOI: 10.1016/b978-0-323-75608-2.00110-5] [Reference Citation Analysis]
2 Koofhethile CK, Rinaldi S, Rassadkina Y, Dinh VB, Gao C, Pallikkuth S, Garcia-Broncano P, de Armas LR, Pahwa R, Cotugno N, Vaz P, Lain MG, Palma P, Yu XG, Shapiro R, Pahwa S, Lichterfeld M. HIV-1 reservoir evolution in infants infected with clade C from Mozambique. Int J Infect Dis 2022;127:129-36. [PMID: 36476348 DOI: 10.1016/j.ijid.2022.11.042] [Reference Citation Analysis]
3 Tettamanti Boshier FA, Reeves DB, Duke ER, Swan DA, Prlic M, Cardozo-Ojeda EF, Schiffer JT. Substantial uneven proliferation of CD4(+) T cells during recovery from acute HIV infection is sufficient to explain the observed expanded clones in the HIV reservoir. J Virus Erad 2022;8:100091. [PMID: 36582473 DOI: 10.1016/j.jve.2022.100091] [Reference Citation Analysis]
4 Khetan P, Liu Y, Dhummakupt A, Persaud D. Advances in Pediatric HIV-1 Cure Therapies and Reservoir Assays. Viruses 2022;14. [PMID: 36560612 DOI: 10.3390/v14122608] [Reference Citation Analysis]
5 Luo R, Fong Y, Boeras D, Jani I, Vojnov L. The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis. The Lancet 2022;400:887-95. [DOI: 10.1016/s0140-6736(22)01492-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang X, Vincent E, Siddiqui S, Turnbull K, Lu H, Blair R, Wu X, Watkins M, Ziani W, Shao J, Doyle-Meyers LA, Russell-Lodrigue KE, Bohm RP, Veazey RS, Xu H. Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth. Nat Commun 2022;13:4823. [PMID: 35973985 DOI: 10.1038/s41467-022-32554-z] [Reference Citation Analysis]
7 Lichterfeld M, Gao C, Yu XG. An ordeal that does not heal: understanding barriers to a cure for HIV-1 infection. Trends Immunol 2022;43:608-16. [PMID: 35905706 DOI: 10.1016/j.it.2022.06.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Hartana CA, Garcia-Broncano P, Rassadkina Y, Lian X, Jiang C, Einkauf KB, Maswabi K, Ajibola G, Moyo S, Mohammed T, Maphorisa C, Makhema J, Yuki Y, Martin M, Bennett K, Jean-Philippe P, Viard M, Hughes MD, Powis KM, Carrington M, Lockman S, Gao C, Yu XG, Kuritzkes DR, Shapiro R, Lichterfeld M. Immune correlates of HIV-1 reservoir cell decline in early-treated infants. Cell Rep 2022;40:111126. [PMID: 35858580 DOI: 10.1016/j.celrep.2022.111126] [Reference Citation Analysis]
9 Berendam SJ, Nelson AN, Yagnik B, Goswami R, Styles TM, Neja MA, Phan CT, Dankwa S, Byrd AU, Garrido C, Amara RR, Chahroudi A, Permar SR, Fouda GG. Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure. Front Immunol 2022;13:885272. [DOI: 10.3389/fimmu.2022.885272] [Reference Citation Analysis]
10 Jacobs TG, Schouwenburg S, Penazzato M, Archary M, Ruel TD, van den Anker J, Burger DM, Cressey TR, Abrams EJ, Lyall H, Bekker A, Colbers A, Burger D, Bekker A, Cressey T, Hirt D, Lutsar I, Mcilleron H, Standing J, Van den Anker J, Svensson E, Abrams E, Amuge P, Archary M, Bekker A, Belew Y, Best B, Burger D, Bygrave H, Capparelli E, Casas E, Clarke D, Clayden P, Colbers A, Cressey T, Dangarembizi M, De Lisa R, Denti P, Domanico P, Essajee S, Frigati L, Giaquinto C, Gibb D, Hackett S, Hazra R, Lallemant M, Lewis L, Lockman S, Mahaka I, Mcfarland B, Meere C, Mir F, Mirochnick M, Mofenson L, Mukui I, Mushavi A, Musiime V, Namusoke-magongo E, Obimbo E, Ojoo MA, Parades R, Perez-casas C, Piccolis M, Pinto J, Puthanakit T, Rakhmanina N, Reinisch A, Rojo P, Rouzier V, Ruel T, Sam-agudu N, Siberry G, Simione T, Simon K, Singh V, Solares M, Sugandhi N, Sylla M, Thior I, Turkova A, Vicari M, Walsh J, Watkins M, Wolf H, Hafiz A, Penazzato M, Rangaraj A, Doherty M, Vitoria M. What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies. The Lancet HIV 2022. [DOI: 10.1016/s2352-3018(22)00121-7] [Reference Citation Analysis]
11 Vieira VA, Herbert N, Cromhout G, Adland E, Goulder P. Role of Early Life Cytotoxic T Lymphocyte and Natural Killer Cell Immunity in Paediatric HIV Cure/Remission in the Anti-Retroviral Therapy Era. Front Immunol 2022;13:886562. [PMID: 35634290 DOI: 10.3389/fimmu.2022.886562] [Reference Citation Analysis]
12 Khanolkar A, Muller WJ, Simpson BM, Cerullo J, Williams R, Sowers SB, Matthews K, Mercader S, Hickman CJ, D’aquila RT, Liu G. Preservation of lymphocyte functional fitness in perinatally-infected and treated HIV+ pediatric patients displaying sub-optimal viral control. Commun Med 2022;2. [DOI: 10.1038/s43856-022-00085-9] [Reference Citation Analysis]
13 Cassidy NAJ, Fish CS, Levy CN, Roychoudhury P, Reeves DB, Hughes SM, Schiffer JT, Benki-Nugent S, John-Stewart G, Wamalwa D, Jerome KR, Overbaugh J, Hladik F, Lehman DA. HIV reservoir quantification using cross-subtype multiplex ddPCR. iScience 2022;25:103615. [PMID: 35106463 DOI: 10.1016/j.isci.2021.103615] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lee GQ, Lichterfeld M. Near-Full-Length Single-Genome HIV-1 DNA Sequencing. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-1871-4_23] [Reference Citation Analysis]
15 Rivera-Megias T, Le NM, Heredia A. Human Hematopoietic Stem Cell (HSC)-Engrafted NSG Mice for HIV Latency Research. Methods Mol Biol 2022;2407:229-51. [PMID: 34985669 DOI: 10.1007/978-1-0716-1871-4_17] [Reference Citation Analysis]
16 Lian X, Gao C, Sun X, Jiang C, Einkauf KB, Seiger KW, Chevalier JM, Yuki Y, Martin M, Hoh R, Peluso MJ, Carrington M, Ruiz-Mateos E, Deeks SG, Rosenberg ES, Walker BD, Lichterfeld M, Yu XG. Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers. Sci Transl Med 2021;13:eabl4097. [PMID: 34910552 DOI: 10.1126/scitranslmed.abl4097] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
17 Lau CY, Adan MA, Maldarelli F. Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection. Viruses 2021;13:2512. [PMID: 34960781 DOI: 10.3390/v13122512] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Patro SC, Niyongabo A, Maldarelli F, Kearney MF. New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir. Viruses 2021;13:2475. [PMID: 34960744 DOI: 10.3390/v13122475] [Reference Citation Analysis]
19 Zaongo SD, Sun F, Chen Y. Are HIV-1-Specific Antibody Levels Potentially Useful Laboratory Markers to Estimate HIV Reservoir Size? A Review. Front Immunol 2021;12:786341. [PMID: 34858439 DOI: 10.3389/fimmu.2021.786341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Moraka NO, Garcia-Broncano P, Hu Z, Ajibola G, Bareng OT, Pretorius-Holme M, Maswabi K, Maphorisa C, Mohammed T, Gaseitsiwe S, VanZyl GU, Kuritzkes DR, Lichterfeld M, Moyo S, Shapiro RL. Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana. AIDS 2021;35:2413-21. [PMID: 34324451 DOI: 10.1097/QAD.0000000000003041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Vieira VA, Adland E, Malone DFG, Martin MP, Groll A, Ansari MA, Garcia-Guerrero MC, Puertas MC, Muenchhoff M, Guash CF, Brander C, Martinez-Picado J, Bamford A, Tudor-Williams G, Ndung'u T, Walker BD, Ramsuran V, Frater J, Jooste P, Peppa D, Carrington M, Goulder PJR. An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults. PLoS Pathog 2021;17:e1010090. [PMID: 34793581 DOI: 10.1371/journal.ppat.1010090] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Amin O, Powers J, Bricker KM, Chahroudi A. Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure. Front Immunol 2021;12:757400. [PMID: 34745130 DOI: 10.3389/fimmu.2021.757400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Tarancón-Diez L, Rull A, Herrero P, Vazquez-Alejo E, Peraire J, Guillén S, Navarro-Gomez ML, Viladés C, Muñoz-Fernandez MÁ, Vidal F. Early antiretroviral therapy initiation effect on metabolic profile in vertically HIV-1-infected children. J Antimicrob Chemother 2021;76:2993-3001. [PMID: 34463735 DOI: 10.1093/jac/dkab277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Dhummakupt A, Persaud D. Capitalizing on Postexposure Antiretroviral Prophylaxis to Restrict Seeding of the Human Immunodeficiency Virus Reservoir. Clin Infect Dis 2021;73:439-40. [PMID: 32503043 DOI: 10.1093/cid/ciaa715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Kuhn L, Paximadis M, Da Costa Dias B, Shen Y, Mncube S, Strehlau R, Shiau S, Patel F, Burke M, Technau KG, Sherman G, Loubser S, Abrams EJ, Tiemessen CT; for the LEOPARD study team. Predictors of cell-associated HIV-1 DNA over one year in very early treated infants. Clin Infect Dis 2021:ciab586. [PMID: 34185838 DOI: 10.1093/cid/ciab586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Katusiime MG, Van Zyl GU, Cotton MF, Kearney MF. HIV-1 Persistence in Children during Suppressive ART. Viruses 2021;13:1134. [PMID: 34204740 DOI: 10.3390/v13061134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Camacho-Gonzalez AF, Palumbo P. HIV in Neonates and Infants. Clin Perinatol 2021;48:275-92. [PMID: 34030814 DOI: 10.1016/j.clp.2021.03.004] [Reference Citation Analysis]
28 Chi BH, Mbori-Ngacha D, Essajee S, Mofenson LM, Tsiouris F, Mahy M, Luo C. Accelerating progress towards the elimination of mother-to-child transmission of HIV: a narrative review. J Int AIDS Soc 2020;23:e25571. [PMID: 32820609 DOI: 10.1002/jia2.25571] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Millar JR, Bengu N, Vieira VA, Adland E, Roider J, Muenchhoff M, Fillis R, Sprenger K, Ntlantsana V, Fatti I, Archary M, Groll A, Ismail N, García-Guerrero MC, Matthews PC, Ndung'u T, Puertas MC, Martinez-Picado J, Goulder P. Early initiation of antiretroviral therapy following in utero HIV infection is associated with low viral reservoirs but other factors determine subsequent plasma viral rebound. J Infect Dis 2021:jiab223. [PMID: 33963757 DOI: 10.1093/infdis/jiab223] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Rinaldi S, de Armas L, Dominguez-Rodríguez S, Pallikkuth S, Dinh V, Pan L, Gӓrtner K, Pahwa R, Cotugno N, Rojo P, Nastouli E, Klein N, Foster C, De Rossi A, Giaquinto C, Rossi P, Palma P, Pahwa S; EPIICAL consortium. T cell immune discriminants of HIV reservoir size in a pediatric cohort of perinatally infected individuals. PLoS Pathog 2021;17:e1009533. [PMID: 33901266 DOI: 10.1371/journal.ppat.1009533] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
31 Powell L, Dhummakupt A, Siems L, Singh D, Le Duff Y, Uprety P, Jennings C, Szewczyk J, Chen Y, Nastouli E, Persaud D. Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trials. J Clin Virol 2021;139:104822. [PMID: 33930698 DOI: 10.1016/j.jcv.2021.104822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Bale MJ, Katusiime MG, Wells D, Wu X, Spindler J, Halvas EK, Cyktor JC, Wiegand A, Shao W, Cotton MF, Hughes SH, Mellors JW, Coffin JM, Van Zyl GU, Kearney MF. Early Emergence and Long-Term Persistence of HIV-Infected T-Cell Clones in Children. mBio 2021;12:e00568-21. [PMID: 33832973 DOI: 10.1128/mBio.00568-21] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
33 Ziani W, Shao J, Wang X, Russell-Lodrigue K, Liu YZ, Montaner LJ, Veazey RS, Xu H. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption. J Virol 2021;95:e02064-20. [PMID: 33408173 DOI: 10.1128/JVI.02064-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Wang X, Xu H. Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption. Viruses 2021;13:335. [PMID: 33670027 DOI: 10.3390/v13020335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
35 Ajibola G, Garcia-Broncano P, Maswabi K, Bennett K, Hughes MD, Moyo S, Mohammed T, Jean-Philippe P, Sakoi M, Batlang O, Lockman S, Makhema J, Kuritzkes DR, Lichterfeld M, Shapiro RL. Viral Reservoir in Early-Treated HIV-Infected Children and Markers for Sustained Viral Suppression. Clin Infect Dis 2021:ciab143. [PMID: 33605999 DOI: 10.1093/cid/ciab143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
36 Avettand-Fenoel V, Lechenadec J, Diallo MS, Fillion M, Melard A, Samri A, Dollfus C, Blanche S, Faye A, Amokrane K, Autran B, Buseyne F, Warszawski J, Frange P; ANRS-EP59-CLEAC Study Group . Initiating Antiretroviral Treatment Early in Infancy Has Long-term Benefits on the Human Immunodeficiency Virus Reservoir in Late Childhood and Adolescence. Clin Infect Dis 2021:ciaa1931. [PMID: 34355738 DOI: 10.1093/cid/ciaa1931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Bekker A, Capparelli EV, Violari A, Cotton MF, Cababasay M, Wang J, Mathiba R, Wiesner L, Wiznia A, Samson P, Browning R, Moye J, Nakwa F, Decloedt E, Rabie H, Mirochnick M, Cressey T. Abacavir Dosing in Neonates from Birth to 3 Months of Life. SSRN Journal. [DOI: 10.2139/ssrn.3863320] [Reference Citation Analysis]
38 Koofhethile CK, Moyo S, Kotokwe KP, Chang C, Mokgethi P, Muchoba L, Mokgweetsi S, Makhema J, Lockman S, Gaseitsiwe S, de Oliveira T, Essex M, Shapiro R, Kanki P, Novitsky V. Detection of Inducible Replication-Competent HIV-1 Subtype C Provirus Despite Long-Term Antiretroviral Treatment in Perinatally Infected Adolescents in Botswana. AIDS Res Hum Retroviruses 2021;37:16-23. [PMID: 32935556 DOI: 10.1089/AID.2020.0097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Cohn LB, Chomont N, Deeks SG. The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies. Cell Host Microbe 2020;27:519-30. [PMID: 32272077 DOI: 10.1016/j.chom.2020.03.014] [Cited by in Crossref: 96] [Cited by in F6Publishing: 76] [Article Influence: 32.0] [Reference Citation Analysis]
40 Obregon-Perko V, Bricker KM, Mensah G, Uddin F, Kumar MR, Fray EJ, Siliciano RF, Schoof N, Horner A, Mavigner M, Liang S, Vanderford T, Sass J, Chan C, Berendam SJ, Bar KJ, Shaw GM, Silvestri G, Fouda GG, Permar SR, Chahroudi A. Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4+ T Cells. J Virol 2020;95:e01669-20. [PMID: 33087463 DOI: 10.1128/JVI.01669-20] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
41 Ruel TD, Capparelli EV, Tierney C, Nelson BS, Coletti A, Bryson Y, Cotton MF, Spector SA, Mirochnick M, LeBlanc R, Reding C, Zimmer B, Persaud D, Bwakura-Dangarembizi M, Naidoo KL, Hazra R, Jean-Philippe P, Chadwick EG. Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study. Lancet HIV 2021;8:e149-57. [PMID: 33242457 DOI: 10.1016/S2352-3018(20)30274-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
42 Falcinelli SD, Kilpatrick KW, Read J, Murtagh R, Allard B, Ghofrani S, Kirchherr J, James KS, Stuelke E, Baker C, Kuruc JD, Eron JJ, Hudgens MG, Gay CL, Margolis DM, Archin NM. Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy. J Infect Dis 2021;224:92-100. [PMID: 33216132 DOI: 10.1093/infdis/jiaa718] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
43 Bricker KM, Obregon-Perko V, Uddin F, Williams B, Uffman EA, Garrido C, Fouda GG, Geleziunas R, Robb M, Michael N, Barouch DH, Chahroudi A. Therapeutic vaccination of SIV-infected, ART-treated infant rhesus macaques using Ad48/MVA in combination with TLR-7 stimulation. PLoS Pathog 2020;16:e1008954. [PMID: 33104758 DOI: 10.1371/journal.ppat.1008954] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
44 Shelton EM, Reeves DB, Bender Ignacio RA. Initiation of Antiretroviral Therapy during Primary HIV Infection: Effects on the Latent HIV Reservoir, Including on Analytic Treatment Interruptions. AIDS Rev 2020;23:28-39. [PMID: 33105471 DOI: 10.24875/AIDSRev.20000001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Powell L, Dhummakupt A, Siems L, Singh D, Duff YL, Uprety P, Jennings C, Szewczyk J, Chen Y, Nastouli E, Persaud D. Clinical Validation of a Quantitative HIV-1 DNA Droplet Digital PCR assay: Applications for Detecting Occult HIV-1 Infection and Monitoring Cell-associated HIV-1 Dynamics across Different Subtypes in HIV-1 Prevention and Cure Trials.. [DOI: 10.1101/2020.09.29.20200154] [Reference Citation Analysis]
46 Bale MJ, Katusiime MG, Wells D, Wu X, Spindler J, Halvas EK, Cyktor JC, Wiegand A, Shao W, Cotton MF, Hughes SH, Mellors JW, Coffin JM, Van Zyl GU, Kearney MF. Early Emergence and Long-Term Persistence of HIV-Infected T Cell Clones in Children.. [DOI: 10.1101/2020.09.15.298406] [Reference Citation Analysis]
47 Palma P, McManus M, Cotugno N, Rocca S, Rossi P, Luzuriaga K. The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV. Lancet HIV 2020;7:e359-65. [PMID: 32386722 DOI: 10.1016/S2352-3018(20)30100-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
48 Shukla A, Ramirez NP, D'Orso I. HIV-1 Proviral Transcription and Latency in the New Era. Viruses 2020;12:E555. [PMID: 32443452 DOI: 10.3390/v12050555] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
49 Ruess H, Lee J, Guzman C, Malladi V, D’orso I. An integrated genomics approach towards deciphering human genome codes shaping HIV-1 proviral transcription and fate.. [DOI: 10.1101/2020.05.01.072231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Boshier FAT, Reeves DB, Duke ER, Swan DA, Prlic M, Cardozo-ojeda EF, Schiffer JT. Blind Uneven Proliferation of CD4+ T cells During Primary Infection Generates the Majority of the HIV Reservoir.. [DOI: 10.1101/2020.04.06.20053231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
51 Dhummakupt A, Rubens JH, Anderson T, Powell L, Nonyane BA, Siems LV, Collinson-Streng A, Nilles T, Jones RB, Tepper V, Agwu A, Persaud D. Differences in inducibility of the latent HIV reservoir in perinatal and adult infection. JCI Insight 2020;5:134105. [PMID: 31999647 DOI: 10.1172/jci.insight.134105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]